Indian pharmaceutical company Alkem MedTech plans to acquire a majority stake in Swiss medtech company Occlutech. Alkem intends to buy up to 55% of Occlutech for EUR 99.4 million, subject to statutory ...

MSCI Inc. is enhancing its index calculation capabilities in alternative and multi-asset classes, including commodities and cryptocurrencies, through the acquisition of index services provider, and ...